Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria

Biomarkers for detection and surveillance of bladder cancer

(2016) Lorne I. Budman et al.   CUAJ-Canadian Urological Association Journal

Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients

(2009) Kun-Lung Chuang et al.   BJU INTERNATIONAL

Reflex UroVysion testing in suspicious urine cytology cases

(2009) Susana Ferra et al.   CANCER CYTOPATHOLOGY

Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer

(2009) Benjamin R. Kipp et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Bladder Cancer Detection Using FISH (UroVysion Assay)

(2008) Kevin C. Halling et al.   ADVANCES IN ANATOMIC PATHOLOGY

Increased efficiency of detecting genetically aberrant cells by UroVysion test on voided urine specimens using automated immunophenotypical preselection of uroepithelial cells

(2008) Gabor Pajor et al.   CYTOMETRY PART A

The use of Urovysion™ fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder

(2008) Michelle D Reid-Nicholson et al.   MODERN PATHOLOGY

The Value of the UroVysion® Assay for Surveillance of Non–Muscle-Invasive Bladder Cancer

(2007) Sigurdur Gudjónsson et al.   EUROPEAN UROLOGY

Urinary Markers in Bladder Cancer

(2007) Olaf P.J. Vrooman et al.   EUROPEAN UROLOGY